Dual Targeting Desensitization with Carfilzomib Plus Lulizumab Significantly Prolongs Kidney Transplant Survival in Allosensitized Nonhuman Primates.
Publication
, Conference
Schroder, PM; Schmitz, R; Fitch, Z; Ezekian, B; Yoon, J; Choi, A; Barbas, A; Leopardi, F; Collins, B; Kwun, J; Knechtle, SJ
Published in: AMERICAN JOURNAL OF TRANSPLANTATION
April 1, 2019
Duke Scholars
Published In
AMERICAN JOURNAL OF TRANSPLANTATION
EISSN
1600-6143
ISSN
1600-6135
Publication Date
April 1, 2019
Volume
19
Start / End Page
429 / 429
Location
Boston, MA
Publisher
WILEY
Conference Name
American Transplant Congress (ATC)
Related Subject Headings
- Surgery
- 3204 Immunology
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Schroder, P. M., Schmitz, R., Fitch, Z., Ezekian, B., Yoon, J., Choi, A., … Knechtle, S. J. (2019). Dual Targeting Desensitization with Carfilzomib Plus Lulizumab Significantly Prolongs Kidney Transplant Survival in Allosensitized Nonhuman Primates. In AMERICAN JOURNAL OF TRANSPLANTATION (Vol. 19, pp. 429–429). Boston, MA: WILEY.
Schroder, P. M., R. Schmitz, Z. Fitch, B. Ezekian, J. Yoon, A. Choi, A. Barbas, et al. “Dual Targeting Desensitization with Carfilzomib Plus Lulizumab Significantly Prolongs Kidney Transplant Survival in Allosensitized Nonhuman Primates.” In AMERICAN JOURNAL OF TRANSPLANTATION, 19:429–429. WILEY, 2019.
Schroder PM, Schmitz R, Fitch Z, Ezekian B, Yoon J, Choi A, et al. Dual Targeting Desensitization with Carfilzomib Plus Lulizumab Significantly Prolongs Kidney Transplant Survival in Allosensitized Nonhuman Primates. In: AMERICAN JOURNAL OF TRANSPLANTATION. WILEY; 2019. p. 429–429.
Schroder, P. M., et al. “Dual Targeting Desensitization with Carfilzomib Plus Lulizumab Significantly Prolongs Kidney Transplant Survival in Allosensitized Nonhuman Primates.” AMERICAN JOURNAL OF TRANSPLANTATION, vol. 19, WILEY, 2019, pp. 429–429.
Schroder PM, Schmitz R, Fitch Z, Ezekian B, Yoon J, Choi A, Barbas A, Leopardi F, Collins B, Kwun J, Knechtle SJ. Dual Targeting Desensitization with Carfilzomib Plus Lulizumab Significantly Prolongs Kidney Transplant Survival in Allosensitized Nonhuman Primates. AMERICAN JOURNAL OF TRANSPLANTATION. WILEY; 2019. p. 429–429.
Published In
AMERICAN JOURNAL OF TRANSPLANTATION
EISSN
1600-6143
ISSN
1600-6135
Publication Date
April 1, 2019
Volume
19
Start / End Page
429 / 429
Location
Boston, MA
Publisher
WILEY
Conference Name
American Transplant Congress (ATC)
Related Subject Headings
- Surgery
- 3204 Immunology
- 3202 Clinical sciences
- 11 Medical and Health Sciences